SCHEMBL6168943

SCHEMBL6168943

O=C(c1ccc(Cl)cc1)c1cc2cc(F)ccc2[nH]1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
NPC1 O15118 2/20 0.65
RAB9A P51151 2/20 0.65
FLT3 P36888 7/20 0.62
KDM4E B2RXH2 1/20 0.60
PDPK1 O15530 1/20 0.60
ALDH1A1 P00352 1/20 0.60
LMNA P02545 1/20 0.60
HPGD P15428 1/20 0.60
TSHR P16473 1/20 0.60
NFKB1 P19838 1/20 0.60
APEX1 P27695 1/20 0.60
CYP2C19 P33261 1/20 0.60
HSD17B10 Q99714 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
RXFP1 Q9HBX9 1/20 0.54
F7 P08709 1/20 0.53
F3 P13726 1/20 0.53
GPR183 P32249 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168411 0.88 MEN1 (0.82) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL6173193 0.85 MEN1 (0.64) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL6169285 0.82 RAB9A (0.65) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL6169053 0.82 GPR183 (0.58) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL6168456 0.80 MEN1 (0.70) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL6389802 0.79 FLT3 (0.80) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL6170035 0.78 MEN1 (0.63) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL213471 0.78 KDM4E (0.72) MEN1KMT2ANPC1RAB9AFLT3
SCHEMBL31060211 0.77 FLT3 (1.00) FLT3KDM4EPDPK1ALDH1A1LMNA
SCHEMBL5507174 0.76 FLT3 (0.80) MEN1KMT2AFLT3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed